- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07765082
Textured Insoles to Restore Sensorimotor Function in Patients With Plantar Fasciopathy (TIRE)
This study will evaluate the immediate effects of wearing textured insoles on gait, postural control, and sensorimotor function in adults with plantar fasciopathy. Researchers will compare functional performance while participants wear textured insoles to determine whether this intervention may improve stability, movement and future studies of longer-term treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Plantar fasciopathy is a common condition that causes heel pain and is associated with impaired sensorimotor function, altered gait, reduced balance and decreased physical function. Current treatments primarily target symptom relief and do not directly address sensorimotor impairments. Textured insoles provide sensory stimulation to the plantar surface of the foot and may improve balance, gait mechanics and functional performance by enhancing plantar cutaneous input. This study will investigate the acute effects of textured insoles on gait, postural control and sensorimotor function in adults with plantar fasciopathy. Results will provide preliminary evidence regarding the feasibility and potential effectiveness of textured insoles as a treatment strategy and inform future studies evaluating longer-term outcomes.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jennifer Xu, PhD
- Phone Number: 8593239850
- Email: jen.xu@uky.edu
Study Locations
-
-
Kentucky
-
Lexington, Kentucky, United States, 40506
- Recruiting
- University of Kentucky - Sports Medicine Research Institute
-
Contact:
- Jennifer Xu, PhD
- Phone Number: 8593239850
- Email: jxu231@uky.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of plantar fasciopathy for at least 3 months
- Able to walk continuously at a self-selected pace for at least 20 minutes
- Able and willing to provide informed consent
Exclusion Criteria:
- Concomitant lower extremity injury (example fracture)
- History of lower extremity injury within the previous 6 months
- History of hip, knee, or ankle surgery involving bones, joints, ligaments, tendons, or cartilage.
- Any condition other than plantar fasciopathy that affects balance or plantar cutaneous sensation.
- Neurological deficits, vestibular disorders, visual disturbances, or other conditions that impair movement or sensory function.
- Pregnancy
- Unable to speak or understand English.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Textured Insole
Participants will wear textured insoles while completing gait, postural control, and sensorimotor function assessments to evaluate the acute effects of the intervention on plantar fasciopathy. |
A textured shoe insole designed to provide plantar sensory stimulation by increasing cutaneous input to the foot during standing and walking. A smooth shoe insole without surface texture used as a control device for comparison with the textured insole. |
|
Sham Comparator: Smooth Insole
Participants will wear a smooth (non-textured) insole while completing the same assessments to serve as the comparison condition in the crossover study. |
A textured shoe insole designed to provide plantar sensory stimulation by increasing cutaneous input to the foot during standing and walking. A smooth shoe insole without surface texture used as a control device for comparison with the textured insole. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Postural Control
Time Frame: Baseline and immediately following completion of each intervention condition during the study visit
|
Postural control will be assessed while participants complete standardized balance testing under each study condition. Performance will be compared between the textured insole and smooth insole conditions to evaluate the acute effects of textured insoles on postural control. |
Baseline and immediately following completion of each intervention condition during the study visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Gait Characteristics
Time Frame: Baseline and immediately following completion of each intervention condition during the study visit.
|
Gait characteristics will be assessed during walking trials under each study condition and compared between the textured and smooth insole conditions. |
Baseline and immediately following completion of each intervention condition during the study visit.
|
|
Change in Plantar Sensation
Time Frame: Baseline and immediately following completion of each intervention condition during the study visit.
|
Plantar sensation will be assessed with the Semmes-Weinstein monofilaments. The detection threshold will be the lightest weight monofilament (grams of force (gf)) that can be perceived by the participant. Lower values indicate better plantar sensation. |
Baseline and immediately following completion of each intervention condition during the study visit.
|
|
Change in Pressure-Pain Threshold
Time Frame: Baseline and immediately following completion of each intervention condition during the study visit.
|
Pressure-pain threshold will be assessed with an algometer. The pressure-pain threshold will be measured in kg/cm2. Higher values indicate better pressure-pain threshold. |
Baseline and immediately following completion of each intervention condition during the study visit.
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 118998
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.